A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis
NCT00293917 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 658
Last updated 2008-02-13
Summary
A study to assess the long-term safety of tacrolimus cream in the treatment of psoriasis
Conditions
Interventions
- DRUG
-
Tacrolimus Cream
Sponsors & Collaborators
-
Astellas Pharma US, Inc.
collaborator INDUSTRY -
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
M Rico, MD · Astellas Pharma US, Inc.
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-31
- Primary Completion
- 2007-08-31
- Completion
- 2007-08-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Etanercept With Tacrolimus for Psoriasis
NCT00134394 ·Status: COMPLETED ·Phase: PHASE2
-
Open Clinical Study, Comparing Non-inferiority of Chronic Plaque Psoriasis
NCT01279629 ·Status: SUSPENDED
-
Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis
NCT02801435 ·Status: COMPLETED ·Phase: PHASE1
-
Systematic Review And Meta-Analysis Of Psoriasis Treatments.
NCT01425138 ·Status: COMPLETED
-
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01163253 ·Status: TERMINATED ·Phase: PHASE3
-
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression
NCT02932878 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis
NCT03880357 ·Status: COMPLETED ·Phase: PHASE1
-
Taltz in Combination With Enstilar for Psoriasis
NCT04372277 ·Status: RECRUITING ·Phase: PHASE4
-
To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis
NCT03331523 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis
NCT00823693 ·Status: COMPLETED ·Phase: PHASE2
-
Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis
NCT04042103 ·Status: COMPLETED ·Phase: PHASE2
-
CT 327 in the Treatment of Psoriasis Vulgaris
NCT00995969 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life
NCT01982552 ·Status: COMPLETED
-
Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis
NCT02969018 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis
NCT00725348 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
NCT06643260 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
NCT03381625 ·Status: COMPLETED ·Phase: PHASE2
-
Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
NCT05172726 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis
NCT03167515 ·Status: COMPLETED ·Phase: NA
-
Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis
NCT00116181 ·Status: COMPLETED ·Phase: PHASE3
-
Psoriasis Inflammation and Systemic Co Morbidities
NCT01170715 ·Status: COMPLETED ·Phase: NA
-
Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
NCT02125279 ·Status: COMPLETED ·Phase: PHASE4
-
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01309737 ·Status: COMPLETED ·Phase: PHASE3
-
Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis
NCT00090129 ·Status: TERMINATED ·Phase: PHASE3
-
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
NCT02564042 ·Status: COMPLETED ·Phase: PHASE2